Founded in 2020, Shanghai Immunocan Biotech Co., Ltd. is a biotechnology company dedicated to building antibody drug discovery platforms using innovative gene editing technology. Our goal is to empower global antibody drug R&D with proprietary gene-edited animal platform generating human and alpaca antibody, suitable for different drug discovery scenarios.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 625 Massachusetts Ave, Cambridge,massachusetts 02139,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://immunocan.com
- HQ
- Cambridge, Massachusetts
Immunocan Questions
Immunocan's website is https://immunocan.com
Immunocan's LinkedIn profile is https://www.linkedin.com/company/immunocan
Immunocan has
4 employees.
View email and phone details for 4
employees at Immunocan.
Immunocan's industry is
Biotechnology Research
Immunocan's top competitors are
Takeda,
Exclcirc Biomed,
Epigenic Therapeutics,
Wave Life Sciences,
Bd,
Wuxi Biologics,
Xtalpi Inc.,
Chemscene,
Kyinno Biotechnology, Inc.,
Novotech.
Immunocan's categories are Biotechnology Research
Immunocan's founding year is 2021
